Following its annual review, Standard & Poor’s affirmed Icade’s and Icade Santé’s long-term rating of BBB+ andshort-term rating of A-2 with a stable outlook.

Contact

Anne-Violette Faugeras

Head of financing and investor relations

Marylou Ravix

Press Relations